Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
about
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivinGlyceollin I, a novel antiestrogenic phytoalexin isolated from activated soyMembrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cellsEndocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells.Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals.The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cellsRon receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell linesExperimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsMechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells.Differentiation of murine embryonic stem cells induces progesterone receptor gene expressionRaloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.Direct transcriptional targets of sex steroid hormones in bone.Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis.Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerFrom estrogen to androgen receptor: a new pathway for sex hormones in prostate.Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivationThe oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptorMethylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells.Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line.Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast CellsDifferential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6.Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.Development and characterization of a tamoxifen-resistant breast carcinoma xenograft.Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity.Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
P2860
Q21195209-25D35AD8-3304-447F-917F-0587140526FFQ24650277-8ED2CC54-3C27-45B6-9F46-3FCEE8DC469EQ24796725-65ED5BDE-F87C-4038-BCB2-4B6BFE695CFDQ24810287-017A078D-8620-4E4A-95FE-B918A901F3EBQ30436239-CD997074-FD98-4C54-B700-B71826637E29Q33241448-CB3CD0E8-C633-4FB4-93A0-EB8818530233Q33583914-5863F597-0661-47F5-9A80-7C8A72232049Q33723377-DD1F568B-0A10-4AF8-90CF-1B29993AA170Q33780223-46E3863B-D25C-415A-921B-59D1221F6626Q33888243-00B39E05-A7B9-4212-8223-943A31957131Q34006827-E6E0FAEE-87BE-40C1-85B2-E3C5CCC3ACC3Q34041328-E99C131A-99DC-4A1E-AF80-D52D2CC9E16AQ34082909-8B00AC3A-E09F-48C1-A387-5AD8ACE03CFEQ34086924-7F3E17F7-753B-46B0-8670-43092D4BDA26Q34312649-C39ABE2C-AE83-4105-AD57-6B36EB935A6BQ34502268-CD25C39F-1A60-4340-A086-35F0BB973B1AQ34758078-D73CF59D-2297-4DBC-9FAD-9A4C241A9EA6Q34914140-102C314E-1FFA-43CD-9AAA-42B48CF3B4F2Q35030765-87F7C247-704A-4E41-B8F3-5021AD4E359DQ35111476-2FC8A7BF-63C5-4881-A64B-F2EF03B24BB2Q35275278-52D92098-F616-4D50-B6D8-547108B8C755Q35571438-04BD9E97-B5C9-4C9C-8CBA-94DEF5D45A5AQ35827822-F5B88D1A-E098-4487-9340-BFC88626FDD3Q35869879-D42401F6-7DDB-4376-8051-6D09EAEEE667Q36067934-FD7262BE-A65D-4A8B-A965-4D3E7C40D171Q36090546-FBD12508-6FE8-4649-8FFB-3CE368D26135Q36138978-BF54B8A0-9F11-4D1B-84FA-D442279F3128Q36292824-2B56BD17-C63B-4B73-81CF-61BF3F4ACD3DQ36294864-0B4DA20C-C1E7-40EB-860F-798501F35E36Q36419975-E3DD3778-D779-42D3-B331-6BE2B5F07A8DQ36457506-E294DBE7-0411-48B5-B9DC-D6941FDAD2EBQ36517144-AE27D59C-3FE5-48A8-85B2-FBDCC369E108Q36587317-11318B11-081A-44D6-B552-A5B3742102C5Q36618242-7FC97684-6FD7-4F9D-8141-410125E2A07AQ36618820-C05CDA2A-0D90-4D19-B50B-9B3A9CD9B0D2Q36620883-41F7979B-D668-4EB9-BA89-E159959CDC94Q36684234-D892F32F-217B-428F-9774-2BC2D97D5CC0Q36827824-1E1585B6-B82D-4859-AC2A-5A63B9A24407Q36919229-9E5C835E-8766-46E5-B79B-50FBAA45CD28Q37013935-4D8437A4-6A12-4C84-9846-2EEA900F5B7B
P2860
Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Models of estrogen receptor re ...... s in breast cancer cell lines.
@en
type
label
Models of estrogen receptor re ...... s in breast cancer cell lines.
@en
prefLabel
Models of estrogen receptor re ...... s in breast cancer cell lines.
@en
P1433
P1476
Models of estrogen receptor re ...... s in breast cancer cell lines.
@en
P2093
P304
P407
P577
1996-05-01T00:00:00Z